Advertisement
PHCUF vs SFOSF
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PHCUF is a Buy and SFOSF is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
PHCUF’s FA Score shows that 1 FA rating(s) are green whileSFOSF’s FA Score has 1 green FA rating(s).
- PHCUF’s FA Score: 1 green, 4 red.
- SFOSF’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
PHCUF’s TA Score shows that 3 TA indicator(s) are bullish while SFOSF’s TA Score has 2 bullish TA indicator(s).
- PHCUF’s TA Score: 3 bullish, 3 bearish.
- SFOSF’s TA Score: 2 bullish, 2 bearish.
Price Growth
PHCUF (@Pharmaceuticals: Other) experienced а +1.69% price change this week, while SFOSF (@Pharmaceuticals: Other) price change was 0.00% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.18%. For the same industry, the average monthly price growth was +122.74%, and the average quarterly price growth was +69.56%.
Industries' Descriptions
@Pharmaceuticals: Other (+3.18% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
| PHCUF | SFOSF | PHCUF / SFOSF | |
| Capitalization | 129M | 10.9B | 1% |
| EBITDA | -2.74M | 6.12B | -0% |
| Gain YTD | 7.143 | 8.593 | 83% |
| P/E Ratio | 500.00 | 11.75 | 4,255% |
| Revenue | 418M | 44.4B | 1% |
| Total Cash | 246M | 16.1B | 2% |
| Total Debt | 6.25M | 30.8B | 0% |
PHCUF | SFOSF | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 30 | 44 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 100 Overvalued | 24 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 89 | 81 | |
PRICE GROWTH RATING 1..100 | 81 | 79 | |
P/E GROWTH RATING 1..100 | 6 | 73 | |
SEASONALITY SCORE 1..100 | n/a | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
SFOSF's Valuation (24) in the null industry is significantly better than the same rating for PHCUF (100). This means that SFOSF’s stock grew significantly faster than PHCUF’s over the last 12 months.
SFOSF's Profit vs Risk Rating (100) in the null industry is in the same range as PHCUF (100). This means that SFOSF’s stock grew similarly to PHCUF’s over the last 12 months.
SFOSF's SMR Rating (81) in the null industry is in the same range as PHCUF (89). This means that SFOSF’s stock grew similarly to PHCUF’s over the last 12 months.
SFOSF's Price Growth Rating (79) in the null industry is in the same range as PHCUF (81). This means that SFOSF’s stock grew similarly to PHCUF’s over the last 12 months.
PHCUF's P/E Growth Rating (6) in the null industry is significantly better than the same rating for SFOSF (73). This means that PHCUF’s stock grew significantly faster than SFOSF’s over the last 12 months.
| PHCUF | SFOSF | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 22% | N/A |
| Stochastic ODDS (%) | 2 days ago 28% | 2 days ago 53% |
| Momentum ODDS (%) | 2 days ago 32% | 5 days ago 53% |
| MACD ODDS (%) | 2 days ago 20% | N/A |
| TrendWeek ODDS (%) | 2 days ago 31% | 2 days ago 50% |
| TrendMonth ODDS (%) | 2 days ago 33% | 2 days ago 44% |
| Advances ODDS (%) | N/A | N/A |
| Declines ODDS (%) | N/A | N/A |
| BollingerBands ODDS (%) | 2 days ago 13% | N/A |
| Aroon ODDS (%) | 2 days ago 38% | N/A |
Advertisement
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| ECCPX | 48.76 | 0.14 | +0.29% |
| Eaton Vance Tax-Managed Multi-Cap Gr C | |||
| RYAVX | 75.88 | 0.16 | +0.21% |
| Rydex S&P MidCap 400 Pure Value H | |||
| VAGVX | 28.85 | 0.06 | +0.21% |
| Vanguard Advice Select Global Value Adml | |||
| CSXCX | 49.07 | 0.03 | +0.06% |
| Calvert US Large Cap Core Rspnb Idx C | |||
| HEMZX | 7.75 | N/A | N/A |
| Virtus SGA Emerging Markets Equity A | |||
PHCUF and
Correlation & Price change
A.I.dvisor indicates that over the last year, PHCUF has been loosely correlated with HLTRF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if PHCUF jumps, then HLTRF could also see price increases.
| Ticker / NAME | Correlation To PHCUF | 1D Price Change % | ||
|---|---|---|---|---|
| PHCUF | 100% | N/A | ||
| HLTRF - PHCUF | 38% Loosely correlated | -2.96% | ||
| INCR - PHCUF | 26% Poorly correlated | +3.95% | ||
| ELAN - PHCUF | 24% Poorly correlated | -0.64% | ||
| MKKGY - PHCUF | 22% Poorly correlated | -0.50% | ||
| CRYM - PHCUF | 20% Poorly correlated | -15.78% | ||
More | ||||
SFOSF and
Correlation & Price change
A.I.dvisor tells us that SFOSF and BIOVF have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SFOSF and BIOVF's prices will move in lockstep.
| Ticker / NAME | Correlation To SFOSF | 1D Price Change % | ||
|---|---|---|---|---|
| SFOSF | 100% | N/A | ||
| BIOVF - SFOSF | 21% Poorly correlated | N/A | ||
| TKPHF - SFOSF | 7% Poorly correlated | +3.82% | ||
| PHCUF - SFOSF | 7% Poorly correlated | N/A | ||
| SGIOF - SFOSF | 5% Poorly correlated | N/A | ||
| TCNNF - SFOSF | 3% Poorly correlated | +8.32% | ||
More | ||||